ARYA Sciences Acquisition Corp V
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARYE research report →
Price Chart
About the company
ARYA Sciences Acquisition Corp V currently has no substantial business activities. This company, established in 2021 and based in New York, New York, was formed with the specific aim of completing a business combination, such as a merger, acquisition of shares or assets, or a reorganization, with one or more entities operating within the healthcare or related sectors.
- CEO
- Adam Leo Stone
- IPO
- 2021
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on ARYE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $198.77M
- P/E
- 11.77
- PEG
- 0.03
- P/S
- 0.00
- P/B
- 0.26
- EV/EBITDA
- -231.75
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 2.27%
- ROIC
- -0.57%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-856,025
- Net Income
- $3.29M+211.1%
- EPS
- $0.88+686.7%
- OCF Growth
- +53.0%
- FCF Growth
- +53.0%
- 52W High
- $10.50
- 52W Low
- $9.70
- 50D MA
- $10.33
- 200D MA
- $10.12
- Beta
- 0.00
- RSI (14)
- 57
- Avg Volume
- 47.10K
No earnings-call transcripts are available for ARYE yet.
- Free Float
- 0.0%
- Shares Outstanding
- 19.19M
- Float Shares
- 0
of shares held by institutions
48 13F filers
Buy/sell ratio 0.60. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Spring Creek Capital LLC | 150.00K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 15, 21 | Stone Adam Leo | other | 499,000 |
| Jul 15, 21 | ARYA Sciences Holdings V | other | 499,000 |
| Jul 15, 21 | ALTMAN MICHAEL SETH | other | 499,000 |
| Jul 12, 21 | Patel Sanjiv | other | 30,000 |
| Jul 12, 21 | Yu Debra | other | 30,000 |
| Jul 12, 21 | ARYA Sciences Holdings V | other | 3,617,500 |
| Jul 12, 21 | EDELMAN JOSEPH | other | 0 |
| Jul 12, 21 | ALTMAN MICHAEL SETH | other | 3,617,500 |
| Jul 12, 21 | Stone Adam Leo | other | 3,617,500 |
| Jul 12, 21 | Wider Todd | other | 30,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ARYE coverage
Recent articles, reports, and earnings notes.
No research on ARYE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ARYE report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.